Minimal Residual Disease Detection and Evolved IGH Clones Analysis in Acute B Lymphoblastic Leukemia Using IGH Deep Sequencing

Acute B lymphoblastic leukemia (B-ALL) is one of the most common types of childhood cancer worldwide and chemotherapy is the main treatment approach. Despite good response rates to chemotherapy regiments, many patients eventually relapse and minimal residual disease (MRD) is the leading risk factor...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Front Immunol
Main Authors: Wu, Jinghua, Jia, Shan, Wang, Changxi, Zhang, Wei, Liu, Sixi, Zeng, Xiaojing, Mai, Huirong, Yuan, Xiuli, Du, Yuanping, Wang, Xiaodong, Hong, Xueyu, Li, Xuemei, Wen, Feiqiu, Xu, Xun, Pan, Jianhua, Li, Changgang, Liu, Xiao
Format: Artigo
Jezik:Inglês
Izdano: Frontiers Media S.A. 2016
Teme:
Immunology
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5048610/
https://ncbi.nlm.nih.gov/pubmed/27757113
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2016.00403
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki